A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form

A simple, accurate, rapid, specific and reproducible UV spectrophotometric method was developed for estimation of content uniformity of atenolol and losartan potassium in its combined tablet dosage form. The method involves formation and solving the simultaneous equation using 226.4 and 254 nm as tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, S. A., Vyas, R. B., Vyas, B. A., Maniyar, N. R., Chauhan, R. S., Shah, D. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178985/
https://www.ncbi.nlm.nih.gov/pubmed/21969756
http://dx.doi.org/10.4103/0250-474X.84599
Descripción
Sumario:A simple, accurate, rapid, specific and reproducible UV spectrophotometric method was developed for estimation of content uniformity of atenolol and losartan potassium in its combined tablet dosage form. The method involves formation and solving the simultaneous equation using 226.4 and 254 nm as two wavelengths for atenolol and losartan, respectively. Developed method was employed to determine the atenolol and losartan content in ten individual tablet units of five market formulations. Methanol was used as solvent. The method was validated. From the results, it was concluded that all brands are within the content uniformity limit, 85-115%.

Ejemplares similares